60
Participants
Start Date
May 16, 2016
Primary Completion Date
October 6, 2016
Study Completion Date
February 28, 2017
ARN-6039
Ascending doses per Cohort
Placebo
Placebo to match ARN-6039
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Arrien Pharmaceuticals
INDUSTRY